proteomics

If the genome is the cell's complete list of recipes, the proteins are the actual dishes being cooked at any moment — and that is what a cell really runs on. A genome tells you what could be made; it does not tell you what is being made right now, in what amounts, or modified in what ways. Proteomics is the large-scale study of all the proteins present in a cell, tissue, or sample at a given time — the proteome.

Because there is no machine that 'reads' a protein letter by letter the way sequencers read DNA, proteomics leans on mass spectrometry. The idea, in plain steps: take a mixture of proteins, chop them into short peptides with an enzyme, then weigh those peptides with extraordinary precision in a mass spectrometer; break each peptide further and weigh the pieces. Because each amino acid has a known mass, the pattern of masses acts like a fingerprint that software matches back to the protein it came from, using the genome's predicted proteins as a lookup table. Comparing the signal strength between samples lets you estimate how much of each protein is present.

Proteomics matters because proteins, not genes, do most of the work, and their levels often do not track their RNA — a gene can be transcribed heavily yet yield little protein, or vice versa. Crucially, it captures things the genome and transcriptome cannot: which proteins carry chemical modifications like phosphorylation, which proteins are bound to which partners, and how all this shifts in disease. The honest limits are technical: mass spectrometry sees abundant proteins far more easily than rare ones, identifications are probabilistic matches rather than certainties, and the proteome is not a fixed list but a moving target that changes minute to minute.